ProCE Banner Activity

My Take on the Latest Developments in Colorectal Cancer at the 2019 Gastrointestinal Cancers Symposium

Clinical Thought
At the 2019 Gastrointestinal Cancers Symposium, important new clinical data were presented on molecular testing, novel immunotherapy strategies, short-course radiation, and low-dose regorafenib in colorectal cancer.

Released: February 07, 2019

Expiration: February 06, 2020

Share

Faculty

John L. Marshall

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

Provided by

Provided by Postgraduate Institute for Medicine
ProCE Banner

Supporters

Supported by educational grants from

Amgen, Inc.

Bayer Healthcare Pharma

Taiho Oncology Inc

Partners

GRACE

ProCE Banner

Faculty Disclosure

Primary Author

John L. Marshall, MD

Associate Professor, Hematology/Oncology
Department of Medicine
Georgetown University Hospital
Washington, DC

John L. Marshall, MD, has disclosed that he has received consulting fees, fees for non-CME/CE services, and funds for research support from Amgen, Bayer, Celgene, Genentech, Merck, and Taiho.